24
Participants
Start Date
May 7, 2022
Primary Completion Date
May 25, 2022
Study Completion Date
May 25, 2022
DFD-29 (Minocycline) Fasting
In each study period, a single 40 mg dose of DFD-29 Capsules will be administered orally with approximately 240 mL of water, in the morning, following a 10-hour overnight fast.
DFD-29 (Minocycline) Fed
In each study period, a single 40 mg dose of DFD-29 Capsules will be administered orally with approximately 240 mL of water, in the morning, following a 10-hour overnight fast and 30 minutes after the start of a high-fat, high-calorie breakfast.
Solodyn (Minocycline) Fasting
In each study period, a single 105 mg dose of SOLODYN® Tablets will be administered orally with approximately 240 mL of water, in the morning, following a 10-hour overnight fast.
CRO, Québec
Lead Sponsor
Collaborators (1)
Dr. Reddy's Laboratories Limited
INDUSTRY
Journey Medical Corporation
INDUSTRY